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Port-site metastases after laparoscopic surgery for gynecologic
malignancies are being reported with increased frequency. The true in-
cidence of port-site metastases among patients with a gynecologic ma-
lignancy who undergo laparoscopic surgery is unknown (Nagarsheth
et al., 2004). In one large case series, the overall risk of such an event
was noted to be 1.18% (Zivanovic et al., 2008). The risk of port-site
metastases amongst the cervical cancer group in this study was 1.25%
(Zivanovic et al., 2008). Various authors have reported port-site
metastases among patients with cervical carcinoma who have had a
laparoscopic procedure (Agostini et al., 2001; Martinez-Palones, 2005;
Yenen et al., 2009; Sert, 2010). The total number of such cases reported
in the literature appears to be less than thirty. Most of these reported
cases involved patients with locally advanced cervical carcinomas
in which only a laparoscopic lymphadenectomy is performed. There is
a paucity of data regarding port-site metastases following robotic-
assisted laparoscopic surgery for gynecologic malignancies (Martinez
et al., 2010). We report a case of a large port-site metastasis following
a robotic-assisted laparoscopic radical hysterectomy and postoperative
adjuvant chemoradiation therapy for early stage squamous cell cervical
carcinoma.⁎ Corresponding author at: Christiana Care Health System, 4755 Ogletown-Stanton
Road, Suite 1905, Newark, DE 19718, USA.
E-mail address: obolles@christianacare.org (O. Bolles).
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The patient presented as a 35 year old G1P1 with irregular vaginal
bleeding. She was noted to have a friable cervical mass. She was diag-
nosed with stage 1B2 squamous cell cervical cancer. Preoperatively,
the patient had a CT of the abdomen and pelvis that demonstrated a
cervical mass measuring 6.0×7.6 cm as well as pelvic and paraaortic
lymphadenopathy. After counseling on various options the patient
underwent a robotic-assisted laparoscopic radical hysterectomy, bi-
lateral salpingectomy, bilateral pelvic and para-aortic lymph node
dissection, and bilateral ovarian transposition. The patient had a
BMI of 38 and no history of prior abdominal surgery. An exam
under anesthesia conﬁrmed a seven to eight cm cervical mass. Five
ports were placed without difﬁculty (see Fig. 1); none of the ports
required replacement during the procedure. The fascia of the 12 mm
ports was closed with the assistance of an Endoclose device. The
skin of all port sites was closed using 4-0 Vicryl. There was no eviden-
ce of intraperitoneal disease at the time of surgery. A pelvic washing
was not performed. The operative time after docking was 5 h and
44 min. The uterus, cervix, and fallopian tubes were removed through
the colpotomy. The lymph nodes were also removed through the
colpotomy after being placed in three separate Endocatch bags.
Intraabdominal irrigation with sterile water was utilized at the end
of the procedure. Estimated blood loss was 300 ml. The patient did
not require blood transfusion and was discharged home less than
24 h after the completion of the procedure. Her ﬁnal pathology report
revealed poorly differentiated invasive squamous cell carcinoma
without lymphovascular space invasion with negative lymph nodes.
The specimen contained an 8.5×6.5×5.5 cm fungating cervical
mass as well as 5 parametrial, 15 pelvic, and 6 paraaortic lymph
nodes which were all negative for metastatic disease. Invasion of
the upper third of the vagina was noted. All margins were negative,
with the closest being 7 mm at the anterior vaginal margin. She re-
ceived chemosensitization with cisplatin and whole pelvic radiation
beginning approximately 6 weeks after this procedure. The patient
subsequently presented with abdominal pain and an abdominal wall
mass located at the umbilicus approximately 5 months after her sur-
gery. Imaging demonstrated a mass measuring 10.5×7.5×10.4 cm
crossing the midline and extending into the pelvis. A PET scan
conﬁrmed likelihood of malignancy of this mass and also suggested
central necrosis. This imaging study also demonstrated a suspicious
right pelvic lymph node. She underwent excision of this mass
(see Fig. 2), measuring approximately 15 cm, with abdominal wall re-
construction with mesh. The mass involved the rectus fascia, rectus
Fig. 1. Diagrammatic representation of port placement.
Fig. 3. Microscopic appearance of abdominal wall lesion.
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exploration a suspicious 3–4 cm right sided lymph node seen on PET
scan was also resected. A bilateral oophorectomy was also performed.
Pathology evaluation of the abdominal wall specimen revealed
moderately differentiated squamous cell carcinoma with negative
margins (see Fig. 3); the lymph node was also described as a moder-
ately differentiated squamous cell carcinoma and noted to have
extranodal extension.
Discussion
Many theories exist regarding the development of port-site metas-
tases in laparoscopic surgery for gynecologic malignancies. Healing
tissue is known to enhance and accelerate tumor growth (Kadar,
1997), perhaps through regulation of vascular endothelial growth fac-
tor (VEGF) by means of hypoxia induced expression of interleukin-
8 (IL-8) (Martinez-Palones, 2005). It has also been proposed that
smaller incisions support tumor growth better than larger ones
(Kadar, 1997). With regard speciﬁcally to laparoscopy, it is thought
that there may be an increase in tumor cells at the port sites caused
by leakage of carbon dioxide gas along the trocars, a phenomenon
referred to as the “chimney effect” (Yenen et al., 2009). This theory
has not been supported by studies involving gasless laparoscopy, asFig. 2. Gross appearance of abdominal wall lesion.there was no decrease in port site metastases when laparoscopy was
performed with a mechanical abdominal wall elevator rather than
with gas insufﬂation (Iwanaka et al., 1998). It is also theorized that
introduction and removal of laparoscopic instruments and ports lead
to port-site metastases through direct inoculation of tumor cells to
the site (Nagarsheth et al., 2004). Tumor spread to port-sites may
occur through direct contact of the sites with the removed specimens
(Nagarsheth et al., 2004).
Laparoscopic port-site metastases in gynecologic cancers tend
to occur in the setting of additional disease recurrence (Zivanovic
et al., 2008). Presence of intraperitoneal disease at the time of lapa-
roscopy for cervical cancer may be a risk factor for port-site metasta-
ses (Martinez-Palones, 2005). In one study, whose primary focus
was ovarian and primary peritoneal carcinoma, presence of ascites
conferred a signiﬁcantly increased risk of port-site metastases; no
cases of port-site metastases were noted in patients who did not
have ascites in this study (Nagarsheth et al., 2004). Another study
suggested that including the port-sites in the radiation ﬁeld resulted
in a lower rate of port-site metastases in gynecologic cancers in
general (Kadar, 1997). With regard to prognosis, it has been noted
that a shorter interval from original laparoscopy to port-site recurrence
is associated with a worse prognosis. Speciﬁcally, port-site recurrence
less than 7 months from the original surgery for any gynecologic
cancer has been shown to signiﬁcantly shorten overall survival when
compared to port-site recurrence at or greater than 7 months from
the original surgery (Zivanovic et al., 2008). It is believed that port-
site metastases should be viewed as advanced disease rather than as
an isolated recurrence (Zivanovic et al., 2008).
Robotic-assisted laparoscopic surgeries are being performed with
increased frequency for gynecologic malignancies. The rate of port-
site metastases in such cases is unknown as few reports exist. One
case of port-site metastasis following a robotic-assisted laparoscopic
radical hysterectomy with bilateral pelvic lymph node dissection
for a cervical adenocarcinoma has been described (Sert, 2010). To
our knowledge, this is the ﬁrst case of port-site metastasis following
a robotic-assisted laparoscopic radical hysterectomy with pelvic
and para-aortic lymph node dissection for a squamous cervical
carcinoma. The recurrence was treated approximately 6.5 months
after the original surgery. At the time of her original surgery, the
patient had no evidence of intraperitoneal disease, ascites, or posi-
tive lymph nodes. The size of the patient's tumor, depth of invasion,
and close vaginal margin did put her at an increased risk of local,
regional or distant recurrence. It remains unknown whether these
characteristics also put patients at an increased risk of port site
metastases.
It has been suggested that fascial closure of all laparoscopic port
sites greater than 5 mm may reduce the risk of port site metastases
(Zivanovic et al., 2008). The peritoneum and fascia were only closed
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occurred at one of those 12 mm port sites which was closed. It has
also been suggested that a reduction in risk of port site metastases
may be seen if the port sites are in an adjuvant radiation ﬁeld
(Kadar, 1997). Our patient's recurrence occurred outside the radia-
tion treatment ﬁeld. Intentional placement of ports within an antici-
pated adjuvant radiation ﬁeld might be a reasonable strategy to
reduce recurrence risk for those patients in whose postoperative
adjuvant radiation seems likely. Other suggested strategies to reduce
the risk of port site recurrence include resection of the lesion en bloc,
placement of the specimen in a retrieval bag, irrigation of the perito-
neal cavity, slow deﬂation of the penumoperitoneum, and irrigation
of port site wounds with povidone–iodine (Tjalma, 2003). Some of
these strategies were utilized in this case and some were not. It is
difﬁcult to determine with any degree of certainty whether this re-
currence could have been delayed or prevented altogether if they
had been utilized. The patient's survival from time of original surgery
was approximately 14 months. This case supports prior data which
demonstrated a decrease in overall survival for patients with port-
site metastases detected less than 7 months after the original surgery.
This case also illustrates the risk of port-site metastases in robotic-
assisted laparoscopic surgery for squamous cell cervical carcinoma
despite negative lymph nodes and negative margins and in the
absence of intraperitoneal disease.Conﬂict of interest statement
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